| 1 |
32928024 | Blunted opioid regulation of the HPA stress response during nicotine withdrawal: therapeutic implications. | 2021 Sep |
1 |
| 2 |
34031099 | Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin. | 2021 May-Jun |
1 |
| 3 |
32050055 | Neuroendocrine effects of naltrexone versus nalmefene in humans. | 2020 Mar |
2 |
| 4 |
30929417 | Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea. | 2019 Mar |
4 |
| 5 |
29264449 | Effects of Opioid Antagonism on Cerebrospinal Fluid Melanocortin Peptides and Cortisol Levels in Humans. | 2017 Oct 1 |
6 |
| 6 |
27659699 | Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals. | 2016 Dec |
1 |
| 7 |
24936803 | Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal. | 2014 Jul |
4 |
| 8 |
20940013 | Opioid receptors and the discriminative stimulus effects of ethanol in squirrel monkeys: Mu and delta opioid receptor mechanisms. | 2011 Jan 10 |
1 |
| 9 |
19837518 | Acute HPA axis response to naltrexone differs in female vs. male smokers. | 2010 May |
2 |
| 10 |
18584566 | Pharmacogenetic treatments for drug addiction: alcohol and opiates. | 2008 |
1 |
| 11 |
17453826 | Beta-endorphin regulation of MAPKs in cultured human articular chondrocytes: MAPK inhibitors prevent the increase of IL-1 beta protein levels during beta-endorphin stimulation. | 2007 Jan-Feb |
1 |
| 12 |
16574767 | Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes. | 2006 Jun |
2 |
| 13 |
16934320 | Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone. | 2006 Sep |
5 |
| 14 |
15939519 | Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment. | 2005 Jun |
1 |
| 15 |
15979578 | Opiate regulation of IL-1beta and TNF-alpha in cultured human articular chondrocytes. | 2005 Aug 12 |
1 |
| 16 |
16088999 | Suppression of the HPA axis stress-response: implications for relapse. | 2005 Jul |
1 |
| 17 |
12689609 | Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys. | 2003 May |
3 |
| 18 |
11862370 | Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. | 2002 Feb |
1 |
| 19 |
12007748 | Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. | 2002 Jun |
1 |
| 20 |
12188097 | Alcohol urge and plasma beta-endorphin change after alcohol challenge with naltrexone pretreatment in social drinkers. | 2002 May |
2 |
| 21 |
12503615 | Specific stimulation of migration of human keratinocytes by mu-opiate receptor agonists. | 2002 Feb-Nov |
1 |
| 22 |
11409748 | Evidence of interactions between melanocortin and opioid systems in regulation of feeding. | 2001 Jun 13 |
1 |
| 23 |
11778142 | Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration. | 2001 Nov |
1 |
| 24 |
10958998 | Uncoupling of proopiomelanocortin (POMC) fragments is related to self-injury. | 2000 Jun |
2 |
| 25 |
10071178 | Stress and self-injurious behavior; hormonal and serotonergic parameters in mentally retarded subjects. | 1999 Jan |
1 |
| 26 |
10195825 | Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study. | 1999 Mar |
1 |
| 27 |
7714138 | Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome. | 1994 Dec |
1 |
| 28 |
8056738 | Effects of the opiate antagonist, naltrexone, on binging antecedents and plasma beta-endorphin concentrations. | 1994 Jun |
2 |
| 29 |
8234900 | Effects of the enkephalin analog (D-Met2,Pro5)-enkephalinamide on alpha-melanocyte-stimulating hormone secretion. | 1993 Sep 3 |
3 |
| 30 |
1291596 | Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women. | 1992 Dec |
1 |
| 31 |
1916633 | A role for beta-endorphin in the pathogenesis of human obesity? | 1991 Jun |
1 |
| 32 |
2098653 | [The role of opioid antagonists in the treatment of obesity. Results of a clinical trial with naltrexone]. | 1990 Apr-Jun |
1 |
| 33 |
2137320 | Naltrexone therapy of apnea in children with elevated cerebrospinal fluid beta-endorphin. | 1990 Jan |
1 |
| 34 |
2475733 | Possible hyperendorphinergic pathophysiology of the Rett syndrome. | 1989 |
1 |
| 35 |
2941636 | A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts. | 1986 Jul 7 |
2 |
| 36 |
2942391 | The effect of beta-endorphin on biogenic amines, insulin, and glucagon levels in the hepatic portal circulation of normal and pancreatectomized dogs. | 1986 Aug |
1 |
| 37 |
2944913 | The effects of naltrexone, an oral beta-endorphin antagonist, in children with the Prader-Willi syndrome. | 1986 Nov |
1 |
| 38 |
3006087 | Use of naltrexone as a provocative test for hypothalamic-pituitary hormone function. | 1986 Feb |
1 |
| 39 |
6088467 | Endocrine and metabolic effects of opiate antagonists. | 1984 Sep |
1 |
| 40 |
6288413 | Naltrexone-insensitive facilitation and naltrexone-sensitive inhibition of passive avoidance behavior of the ACTH-(4-9) analog (ORG 2766) are located in two different parts of the molecule. | 1982 Jul 16 |
2 |